Lack of Tau Proteins Rescues Neuronal Cell Death and Decreases Amyloidogenic Processing of APP in APP/PS1 Mice

Leroy, Karelle, Ando, Kunie, Laporte, Vincent, Dedecker, Robert, Suain, Valérie, Authelet, Michèle, Héraud, Céline, Pierrot, Nathalie +3 more·2012·The American Journal of Pathology
DOI 10.1016/j.ajpath.2012.08.012

Cited by (161)

Items 101–161 of 161

  1. The role of astrocytes in Alzheimer's disease: Pathophysiology, biomarkers, and therapeutic potential
    Md. Joynal Abedin, Ksenia V. Kastanenka · 2026 · Journal of Alzheimer s Disease
  2. Physiological expression of mutated TAU impaired astrocyte activity and exacerbates β-amyloid pathology in 5xFAD mice
    Dorit Farfara, Meital Sooliman, Limor Avrahami, Tabitha Grace Royal, Shoshik Amram, Lea Rozenstein‐Tsalkovich, Dorit Trudler, Shani Blanga‐Kanfi, Hagit Eldar-Finkelman, Jens Pahnke et al. · 2023 · Journal of Neuroinflammation
  3. Motor Cortex Theta and Gamma Architecture in Young Adult APPswePS1dE9 Alzheimer Mice
    Anna Papazoglou, Julien Soós, Andreas Lundt, Carola Wormuth, Varun Raj Ginde, Ralf Müller, Christina Henseler, Karl Broich, Kan Xie, Britta Haenisch et al. · 2017 · PLoS ONE
  4. ALWPs Improve Cognitive Function and Regulate Aβ Plaque and Tau Hyperphosphorylation in a Mouse Model of Alzheimer’s Disease
    Youngpyo Nam, Bitna Joo, Ju‐Young Lee, Kyung‐Min Han, Ka‐Young Ryu, Young Ho Koh, Jeongyeon Kim, Ja Wook Koo, Young-Man We, Hyang‐Sook Hoe · 2019 · Frontiers in Molecular Neuroscience
  5. In Vitro and In Vivo Neuroprotective Effects of Etifoxine in β-Amyloidinduced Toxicity Models
    Véronique Riban, Johann Meunier, Dorothée Buttigieg, Vanessa Villard, Marc Verleye · 2020 · CNS & Neurological Disorders - Drug Targets
  6. Heparan sulfate proteoglycans: Mediators of cellular and molecular Alzheimer's disease pathogenic factors via tunnelling nanotubes?
    Duy LB Nguyen, Rachel K. Okolicsanyi, Larisa Margaret Haupt · 2024 · Molecular and Cellular Neuroscience
  7. Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer’s disease pathology progression
    Kunié Ando, Fahri Küçükali, Emilie Doeraene, Siranjeevi Nagaraj, Eugenia Maria Antonelli, May Thazin Htut, Zehra Yilmaz, Andreea‐Claudia Kosa, Lidia Lopez‐Gutierrez, Carolina Quintanilla‐Sánchez et al. · 2024 · Acta Neuropathologica
  8. Importance of tau in cognitive decline as revealed by developmental exposure to lead
    Kristal Wright, Syed Waseem Bihaqi, Asma Lahouel, Anwar M. Masoud, Foqia Mushtaq, Allison Leso, A. Eid, Nasser H. Zawia · 2017 · Toxicology Letters
  9. AAV delivery of artificial miRNA targeting MAPT for the reduction of tau pathology in Alzheimer’s disease
    Jessica M. Hogestyn, Erik Wischhof, Yao Chen, Tiffany Chan, Brenda Richards, Thangaaishwarya Mahendran, Johanna Adams, Daniel Dubreuil, Jie Bu, Robert Jackson et al. · 2025 · Molecular Therapy
  10. Toluidine blue O attenuates tau phosphorylation in N2a-APPSwe cells
    Seda Önder, Kevser Biberoğlu, Melike Yuksel, Özden Tacal · 2022 · Chemico-Biological Interactions
  11. A Polyaminobiaryl-Based β-secretase Modulator Alleviates Cognitive Impairments, Amyloid Load, Astrogliosis, and Neuroinflammation in APPSwe/PSEN1ΔE9 Mice Model of Amyloid Pathology
    Marie Tautou, Florian Descamps, Paul-Emmanuel Larchanché, Luc Buée, Jamal El Bakali, Patricia Melnyk, Nicolas Sergeant · 2023 · International Journal of Molecular Sciences
  12. Amyloid β Hypothesis in the Development of Therapeutic Agents for Alzheimer’s Disease
    Adegoke O. Adeniji, P.W. Adams, Vicky V. Mody · 2016 · Elsevier eBooks
  13. Intravenous Injection of PHF-Tau Proteins From Alzheimer Brain Exacerbates Neuroinflammation, Amyloid Beta, and Tau Pathologies in 5XFAD Transgenic Mice
    Sarah Houben, Marie-Ange de Fisenne, Kunié Ando, Virginie Vanden Dries, Luc Poncelet, Zehra Yilmaz, Salwa Mansour, Robert De Decker, Jean‐Pierre Brion, Karelle Leroy · 2020 · Frontiers in Molecular Neuroscience
  14. The Kv7 channel opener Retigabine reduces neuropathology and alleviates behavioral deficits in APP/PS1 transgenic mice
    Dongpei Zhuang, Nan yu, Han Shuo, Xinyao Zhang, Chuanxia Ju · 2024 · Behavioural Brain Research
  15. Biomarkers and Target-Specific Small-Molecule Drugs in Alzheimer’s Diagnostic and Therapeutic Research: From Amyloidosis to Tauopathy
    Sheng Li, Rajiv Bhalla · 2024 · Neurochemical Research
  16. Small-Molecule Inhibitors of Amyloid Beta: Insights from Molecular Dynamics—Part B: Natural Compounds
    Mariyana Atanasova · 2025 · Pharmaceuticals
  17. E2F4DN Transgenic Mice: A Tool for the Evaluation of E2F4 as a Therapeutic Target in Neuropathology and Brain Aging
    Morgan Ramón‐Landreau, Cristina Sánchez‐Puelles, Noelia López‐Sánchez, Anna Lozano-Ureña, Aina M. Llabrés-Mas, José María Frade · 2022 · International Journal of Molecular Sciences
  18. Alzheimer’s disease and epilepsy: Research hotspots for comorbidity in the era of global aging
    Xu Zhou, Yang Liu, Zhengjuan Wu, Xiaolu Zhang, Hua Tao · 2024 · Epilepsy & Behavior
  19. Dysregulation of Inositol Polyphosphate 5-Phosphatase OCRL in Alzheimer’s Disease: Implications for Autophagy Dysfunction
    Kunié Ando, May Thazin Htut, Eugenia Maria Antonelli, Andreea‐Claudia Kosa, Lidia Lopez‐Gutierrez, Carolina Quintanilla‐Sánchez, Emmanuel Aydin, Emilie Doeraene, Siranjeevi Nagaraj, Ana Raquel Ramos et al. · 2025 · International Journal of Molecular Sciences
  20. Axonal tau reduction ameliorates tau and amyloid pathology in a mouse model of Alzheimer’s disease
    Abdolhossein Zare, Saeede Salehi, Jakob Maximilian Bader, Anna-Lena Wiessler, Manuela Prokesch, Vincent Albrecht, Carmen Villmann, Matthias Mann, Michael Briese, Michael Sendtner · 2025 · Translational Neurodegeneration
  21. The Determinant of Tau Spreading in Alzheimer’s Disease: Dependent on Senile Plaque, Neural Circuits, or Spatial Proximity?
    Yuichi Riku, Jean‐Pierre Brion, Kunié Ando, Toshiki Uchihara, Yasushi Iwasaki · 2025 · International Journal of Molecular Sciences
  22. Excitoprotective effects of conditional tau reduction in excitatory neurons and in adulthood
    Yuliya Voskobiynyk, Zhiyong Li, J. Nicholas Cochran, M. Natalie Davis, Nancy V. N. Carullo, Rose B. Creed, Susan C. Buckingham, Alicia M. Hall, Scott M. Wilson, Erik D. Roberson · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  23. Deletion of Murine APP Aggravates Tau and Amyloid Pathologies in the 5xFADXTg30 Alzheimer’s Disease Model
    Kunié Ando, Andreea‐Claudia Kosa, Yasmina Mehadji, Hinde Lasri, Lidia Lopez‐Gutierrez, Carolina Quintanilla‐Sánchez, Emmanuel Aydin, Emilie Doeraene, Alain Wathelet‐Depauw, Siranjeevi Nagaraj et al. · 2025 · Biomolecules
  24. Chondroitin Sulfate‐Coated Heteroduplex‐Molecular Spherical Nucleic Acids
    Toni Laine, Prasannakumar Deshpande, Ville Tähtinen, Eleanor T. Coffey, Pasi Virta · 2024 · ChemBioChem
  25. Sex-specific changes in energy demand during the preplaque stage in a transgenic Alzheimer’s mouse model
    Rongwan Sun, Leonie-Kim Zimbalski, Stefanie Schreyer, David Baidoe‐Ansah, Aida Harutyunyan, Arnd Heuser, Rachel N. Lippert, Joachim Spranger, Knut Mai, Sebastian Brachs · 2025 · Biology of Sex Differences
  26. Nanoscopic Mapping of the Extracellular Space in Amyloid Plaque‐rich Cortex
    Juan Estaún‐Panzano, Yulia Dembitskaya, Ivo Calaresu, Somen Nandi, Quentin Gresil, Évelyne Doudnikoff, Thierry Lesté-Lasserre, Thierry Amédée, Laurent Cognet, Laurent Groc et al. · 2025 · Advanced Science
  27. PolyGR-containing aggregates link with pathology and clinical features of Alzheimer’s disease
    Huong T. Phuong, Rodrigo Francisco Tomas, Cemal Akmese, Ana María Piddo Mijares, Isabella M. Gerstin, Shu Guo, Logan R. Bell, Ross Ellwood, Svitlana Yegorova, Stefani K. Ng et al. · 2025 · Acta Neuropathologica
  28. Application of the Movable Type Free Energy Method to the Caspase-Inhibitor Binding Affinity Study
    Song Xue, Hao Liu, Zheng Zheng · 2019 · International Journal of Molecular Sciences
  29. Alzheimer’s disease
    Charles J. Duyckaerts · 2014 · Cambridge University Press eBooks
  30. Moderate Overexpression of Tau in Drosophila Exacerbates Amyloid-β-Induced Neuronal Phenotypes and Correlates with Tau Oligomerization
    Laëtitia Miguel, Thierry Frébourg, Dominique Campion, Magalie Lecourtois · 2020 · Journal of Alzheimer s Disease
  31. Effect of the Icelandic Mutation APPA673T in the Murine APP Gene on Phenotype of Line 66 Tau Mice
    Anne Anschuetz, Lianne Robinson, Miguel Mondésir, Valeria Melis, Bettina Platt, Charles R. Harrington, Gernot Riedel, Karima Schwab · 2025 · Biomolecules
  32. Targeting cholinergic cells in a mouse model of Alzheimer's disease: Validating a quadruple transgenic model
    Szidónia Farkas, Viktor Jasper, Kinga Nyers-Marosi, Bence Petrovai, Adrienn Szabó, Erika Kvak, Csenge Sólyomvári, Réka Varga, Viktória Kormos, Géza Makkai et al. · 2026 · Experimental Neurology
  33. Contribution of Nucleic Acids in the Pathogenesis of Alzheimer’s Disease
    A. A. Farooqui · 2017 · Elsevier eBooks
  34. Nano/Micro-Assisted Regenerative Medicine
    Soo-Hong Lee · 2018 · MDPI eBooks
  35. Tau Ablation Rewires Brain Cell Programs in Health and Restores Function in Disease
    Chimal-Juárez, Enrique, Patel, Henika, Jury-Garfe, Nur, Dabin, Luke C., Vidal, Ruben, Kim, Jungsu, Lasagna-Reeves, Cristian A. · 2026 · bioRxiv
  36. Factors that Contribute to de novo Protein Misfolding and Prion Formation in Saccharomyces cerevisiae
    Kathryn M. Keefer · 2017 · Open Scholarship Institutional Repository (Washington University in St. Louis)
  37. The Interplay of Progestins, Matrix Metalloproteinases, and the Aging Brain
    Keyana Nicole Porter · 2020
  38. The Longitudinal Relationships between Biomarkers of Alzheimer’s Disease
    Saffire Hanna Krance · 2019 · TSpace (University of Toronto)
  39. INVESTIGATION INTO THE FUNCTIONAL ROLES OF TAU AND ALPHA-SYNUCLEIN IN NEURODEGENERATIVE DISEASE
    Meaghan Morris · 2014
  40. Quantification and Analysis of Tau Protein Effects on Microtubule Dynamics in Mammalian (LLC-PK1) Cells
    Alexandra Doersch · 2020 · University of Minnesota Digital Conservancy (University of Minnesota)
  41. N-truncated Aβ4-x peptides in Alzheimer's disease: generation, degradation, and relationship with neuropathological hallmarks
    Silvia Zampar · 2021
  42. Faculty Opinions recommendation of Tau deletion reduces plaque-associated BACE1 accumulation and decelerates plaque formation in a mouse model of Alzheimer's disease.
    Riqiang Yan · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  43. Quantitative Analysen hippocampaler Interneuronen in zwei transgenen Alzheimer Mausmodellen
    Naomi Kristin Giesers · 2022
  44. Prevention of tau accumulation through inhibition of hnRNP R-dependent axonal Mapt mRNA localization
    Abdolhossein Zare, Saeede Salehi, Michael Briese, Michael Sendtner · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  45. Decoding Amyloid Plaque Penetrability: Exploring Extracellular Space and Rheology in Plaque-rich Cortex
    Juan Estaún‐Panzano, Yulia Dembitskaya, Ivo Calaresu, Somen Nandi, Quentin Gresil, Évelyne Doudnikoff, Thierry Lesté-Lasserre, Thierry Amédée, Laurent Cognet, Laurent Groc et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  46. Molecular chaperones as therapeutic gatekeepers in Alzheimer’s disease: Intersections with Tau aggregation, amyloid burden, and neuroinflammation
    Yukti, Anushka Sharma, Sarthak Dhar, Rupal Ojha, Vijay Kumar Prajapati · 2025 · Advances in protein chemistry and structural biology
  47. Investigation of three flavonoids as potent tau aggregation inhibitors and In vivo demonstration of myricetin
    Bogdan M. Benin, Trae Hillyer, Bovinari Alistair Csubak, Noah Aguirre, Samuel D. Crish, Chounghun Kang, Woo Shik Shin · 2025 · Pharmacological Research - Natural Products
  48. Additional file 4 of Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology
    Vanessa Laversenne, Sameer Nazeeruddin, Emma Källstig, Colin, Philippe, Christel Voize, Bernard Laurent Schneider · 2020 · Figshare
  49. Additional file 2 of Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology
    Vanessa Laversenne, Sameer Nazeeruddin, Emma Källstig, Colin, Philippe, Christel Voize, Bernard Laurent Schneider · 2020 · Figshare
  50. Additional file 5 of Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology
    Vanessa Laversenne, Sameer Nazeeruddin, Emma Källstig, Colin, Philippe, Christel Voize, Bernard Laurent Schneider · 2020 · Figshare
  51. Additional file 3 of Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology
    Vanessa Laversenne, Sameer Nazeeruddin, Emma Källstig, Colin, Philippe, Christel Voize, Schneider, Bernard L. · 2020 · Figshare
  52. Additional file 1 of Physiological expression of mutated TAU impaired astrocyte activity and exacerbates β-amyloid pathology in 5xFAD mice
    Dorit Farfara, Meital Sooliman, Limor Avrahami, Tabitha Grace Royal, Shoshik Amram, Lea Rozenstein‐Tsalkovich, Dorit Trudler, Shani Blanga‐Kanfi, Hagit Eldar-Finkelman, Jens Pahnke et al. · 2023 · Figshare
  53. Additional file 2 of Physiological expression of mutated TAU impaired astrocyte activity and exacerbates β-amyloid pathology in 5xFAD mice
    Dorit Farfara, Meital Sooliman, Limor Avrahami, Tabitha Grace Royal, Shoshik Amram, Lea Rozenstein‐Tsalkovich, Dorit Trudler, Shani Blanga‐Kanfi, Hagit Eldar-Finkelman, Jens Pahnke et al. · 2024 · Figshare
  54. Additional file 6 of Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology
    Vanessa Laversenne, Sameer Nazeeruddin, Emma Källstig, Colin, Philippe, Christel Voize, Schneider, Bernard L. · 2020 · Figshare
  55. Additional file 1 of Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology
    Vanessa Laversenne, Sameer Nazeeruddin, Emma Källstig, Colin, Philippe, Christel Voize, Schneider, Bernard L. · 2020 · Figshare
  56. Transmission of Alzheimer pathology in murine and primate models : from proteinopathies to neuronal and cognitive impairments
    Suzanne Lam · 2021 · theses.fr (ABES)
  57. Role of extracellular space in neurodegenerative diseases
    Juan Estaún‐Panzano · 2024
  58. Sleeve gastrectomy improves cognition by enhancing central ERK/CREB/BDNF pathway through increased GIP secretion
    Zhaoyinling Wei, Jie Yang, Yingdan Qiao, Shuo Wang, Yuli Cai, Ling Gao · 2026 · iScience
  59. Tau reduction counteracts transcriptomic and behavioral abnormalities in an Alzheimer amyloid model
    Sara J. Knowles, Cathrine Sant, Pranav Nambiar, Rafaella Araujo Gonçalves, Kaitlyn Ho, Gui-Qiu Yu, Reuben Thomas, Megumi Mori, Lane Domke, Victor Huang et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  60. Effect of tau silencing on tau pathology propagation, a treatment efficient at the earliest stages of the disease?
    Andreea‐Claudia Kosa, Lidia Lopez‐Gutierrez, Kunié Ando, Emilie Doeraene, Emmanuel Aydin, Hinde Lasri, Alain Wathelet‐Depauw, Karlien Pieters, David Van Morckhoven, Christine Dubois et al. · 2026 · Neurobiology of Disease
  61. Pathophysiological Characterization of intra‐ and extracellularly aggregated Amyloid Peptides in Dementias
    Anika Saul · 2013